Mei T - Search Results

1

Comparison of the Efficacy and Safety of Perioperative Immunochemotherapeutic Strategies for Resectable Non-small Cell Lung Cancer: a Systematic Review and Network Meta-analysis.

Mei T, Zhou Q, Gong Y. Mei T, et al. Clin Oncol (R Coll Radiol). 2024 Feb;36(2):107-118. doi: 10.1016/j.clon.2023.12.006. Epub 2023 Dec 21. Clin Oncol (R Coll Radiol). 2024. PMID: 38151439

2

Impact of antibiotic use before definitive concurrent chemoradiation in patients with locally advanced non-small cell lung cancer.

Mei T, Yang X, Yu M, Tian X, Deng Q, Chen X, Gong Y. Mei T, et al. Strahlenther Onkol. 2023 Jul;199(7):645-657. doi: 10.1007/s00066-022-02027-9. Epub 2022 Dec 9. Strahlenther Onkol. 2023. PMID: 36484821

3

Survival of Patients With Inoperable Non-Small Cell Lung Cancer With Baseline Severe Pulmonary Dysfunction: Impacts of Thoracic Radiotherapy and Predictive Analysis for Acute Radiation Pneumonitis.

Deng Q, Zhang Y, Li Y, Mei T, Yang X, Tian X, Chen X, Gong Y. Deng Q, et al. Among authors: mei t. Oncology (Williston Park). 2023 Jan 26;37(1):26-33. doi: 10.46883/2023.25920983. Oncology (Williston Park). 2023. PMID: 36724139 Free article.

4

The safety of combining immune checkpoint inhibitors and platinum-based chemotherapy for the treatment of solid tumors: A systematic review and network meta-analysis.

Mei T, Wang T, Deng Q, Gong Y. Mei T, et al. Front Immunol. 2023 Feb 7;14:1062679. doi: 10.3389/fimmu.2023.1062679. eCollection 2023. Front Immunol. 2023. PMID: 36825025 Free PMC article.

5

The quality and clinical translation of radiomics studies based on MRI for predicting Ki-67 levels in patients with breast cancer.

Wang M, Mei T, Gong Y. Wang M, et al. Among authors: mei t. Br J Radiol. 2023 Oct;96(1150):20230172. doi: 10.1259/bjr.20230172. Epub 2023 Sep 19. Br J Radiol. 2023. PMID: 37724784 Free PMC article. Review.

6

Pathological complete response to neoadjuvant therapy with serplulimab and chemotherapy in stage IIIB small cell lung cancer: a case report and literature review.

Mei T, Wang T, Lei C, Jiang D, Zhou Q. Mei T, et al. Front Immunol. 2024 Jan 18;14:1272450. doi: 10.3389/fimmu.2023.1272450. eCollection 2023. Front Immunol. 2024. PMID: 38304254 Free PMC article. Review.

7

First-line treatment of driver gene-negative metastatic lung adenocarcinoma with malignant pleural effusion: Should chemotherapy be combined with an immune checkpoint inhibitor or bevacizumab?

Zhao Y, Mei T, Na F, Tian X, Ao R, Long X, Luo Q, Duan P, Zhu J, Wang Y, Huang M, Liu Y, Gong Y. Zhao Y, et al. Among authors: mei t. Invest New Drugs. 2024 Apr;42(2):196-206. doi: 10.1007/s10637-024-01424-4. Epub 2024 Feb 22. Invest New Drugs. 2024. PMID: 38386170 Free PMC article.

8

Multi-omics and artificial intelligence predict clinical outcomes of immunotherapy in non-small cell lung cancer patients.

Mei T, Wang T, Zhou Q. Mei T, et al. Clin Exp Med. 2024 Mar 30;24(1):60. doi: 10.1007/s10238-024-01324-0. Clin Exp Med. 2024. PMID: 38554212 Free PMC article. Review.

9

Surgery/non-surgery-based strategies for invasive locally-advanced non-small cell lung cancer in the era of precision medicine.

Wang M, Wang B, Chen X, Mei T, Yang X, Luo Q, Na F, Gong Y. Wang M, et al. Among authors: mei t. Am J Surg. 2024 Dec 4;240:116132. doi: 10.1016/j.amjsurg.2024.116132. Online ahead of print. Am J Surg. 2024. PMID: 39667297

10

Prognostic and immunological characteristics of CDK1 in lung adenocarcinoma: A systematic analysis.

Du Q, Liu W, Mei T, Wang J, Qin T, Huang D. Du Q, et al. Among authors: mei t. Front Oncol. 2023 Mar 6;13:1128443. doi: 10.3389/fonc.2023.1128443. eCollection 2023. Front Oncol. 2023. PMID: 36950551 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

486 results

Search Page

Filters